Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream



Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): $156.36

1.12 (+0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add JAZZ to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Jazz Pharmaceuticals plc (JAZZ) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering JAZZ.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 15 $250 $172 $204.937 $155.67 31.65%
2021-11-11 15 $250 $172 $204.312 $155.67 31.25%
2021-11-16 15 $250 $172 $204.125 $155.67 31.13%
2021-12-17 14 $250 $172 $203.812 $155.67 30.93%
2021-12-20 14 $250 $172 $201.937 $155.67 29.72%
2022-01-06 14 $250 $172 $202.312 $155.67 29.96%
2022-01-13 14 $250 $172 $202.812 $155.67 30.28%
2022-01-23 14 $250 $172 $204.562 $155.67 31.41%
2022-02-11 12 $250 $172 $204.437 $155.67 31.33%
2022-02-25 11 $250 $172 $204.437 $155.67 31.33%
2022-03-02 12 $250 $172 $202.866 $155.67 30.32%
2022-03-04 14 $250 $172 $202.266 $155.67 29.93%
2022-03-28 14 $250 $174 $203.466 $155.67 30.7%

The Trend in the Analyst Price Target


Over the past 138 days, JAZZ's average price target has gone down $1.47.

Over the past 51 weeks, JAZZ's average upside potential has been 36.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 7 236 176 204.350 174.59 17.05%
2021-08-14 18 250 176 209.820 142.16 47.59%
2021-11-14 15 250 172 204.125 139.53 46.29%
2022-01-23 13 250 172 204.562 136.76 49.58%
2022-02-11 12 250 172 204.437 141.95 44.02%

JAZZ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.21 12 1 1 0 0 14

The Trend in the Broker Recommendations


Over the past 120 days, JAZZ's average broker recommendation rating worsened by 0.01.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for JAZZ as an investment opportunity.

  • In terms of how Jazz Pharmaceuticals plc fares relative to all US stocks, note that its average analyst price target is higher than 1601.36% of that group.
  • JAZZ has a higher number of analysts covering the stock than 1611.78% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, Jazz Pharmaceuticals plc's upside potential (average analyst target price relative to current price) is higher than 255.3% of them.
  • JAZZ has a lower variance in analysts' estimates than -465.15% of Pharmaceutical Products stocks.

Stocks similar to Jazz Pharmaceuticals plc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IONS, HZNP, and GSK.

Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4069 seconds.